AZT (zidovudine) may act postintegrationally to inhibit generation of HIV-1 progeny virus in chronically infected cells (Q45860297)

17 December 2017

title

AZT (zidovudine) may act postintegrationally to inhibit generation of HIV-1 progeny virus in chronically infected cells (English)

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

30 October 2022

1 reference

R. Rooke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1691885

30 October 2022

M. Tremblay

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1691885

30 October 2022

M. A. Wainberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1691885

30 October 2022

language of work or name

English

0 references

publication date

1 May 1990

1 reference

17 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:004268229090245M?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

https://api.elsevier.com/content/article/PII:004268229090245M?httpAccept=text/plain

30 October 2022

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

30 October 2022

1 reference

17 December 2017

volume

176

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

205-215

1 reference

17 December 2017

Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

Genetic variation in AIDS viruses

30 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

Molecular cloning and primary nucleotide sequence analysis of a distinct human immunodeficiency virus isolate reveal significant divergence in its genomic sequences

30 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

30 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes

30 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.

30 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay

30 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions

30 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

30 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

Site-specific mutagenesis of AIDS virus reverse transcriptase

30 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus

30 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

Effect of 3'-azido-2',3'-dideoxythymidine (AZT) and neutralizing antibody on human immunodeficiency virus (HIV)-induced cytopathic effects: implication of giant cell formation for the spread of virus in vivo

30 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

30 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene.

30 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

30 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

The accuracy of reverse transcriptase from HIV-1.

30 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy

30 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

Suppression of mouse viraemia and retroviral disease by 3'-azido-3'-deoxythymidine

30 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

30 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

Variable and conserved neutralization antigens of human immunodeficiency virus

30 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex

30 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0042-6822(90)90245-M

30 October 2022

Identifiers

1 reference

17 December 2017

1 reference

17 December 2017